Technology The First Crispr Medicine Is Now Approved in the US Kevin Colleran Dec 11, 2023 Casgevy uses the Nobel Prize–winning technology Crispr to modify patients’ cells so that they produce healthy hemoglobin… Read More...
Technology The Second Person to Get a Pig Heart Transplant Just Died Kevin Colleran Nov 1, 2023 Lawrence Faucette, the 58-year-old patient with terminal heart disease who was the second person to receive a… Read More...
Technology A Gene Therapy Cure for Sickle Cell Is on the Horizon Kevin Colleran Mar 15, 2023 Evie Junior’s life has been defined by pain. He was born with sickle cell disease, which causes red blood cells to be… Read More...
Health Eascra Biotech Selected as Finalist for 2023 SXSW Pitch James Pereira Jan 18, 2023 BOSTON, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Eascra Biotech, a new start-up building the next generation of therapeutic… Read More...
Health Gene Editing for Cardiac Protection James Pereira Jan 15, 2023 CRISPR-Cas9, the gene editing approach was found to confer protection from ischemia/reperfusion injury, according to a… Read More...
Technology Here’s What’s Next for Pig Organ Transplants Kevin Colleran Dec 26, 2022 Starting in the 1960s, doctors attempted transplants of kidneys, hearts, and livers from baboons and chimpanzees—humans’… Read More...
Technology A More Elegant Form of Gene Editing Progresses to Human Testing Kevin Colleran Dec 23, 2022 In April 2016, Waseem Qasim, a professor of cell and gene therapy, was captivated by a new scientific paper that… Read More...
Technology The Crispr Baby Scientist Is Back. Here’s What He’s Doing Next Kevin Colleran Dec 21, 2022 Some scientists and ethicists think He deserves a chance to prove that he’s capable of producing scientifically valid… Read More...
Technology Turns Out Fighting Mosquitoes With Mosquitoes Actually Works Kevin Colleran Nov 21, 2022 The Aedes aegypti mosquito is not just a nuisance—it’s a known carrier of dengue, yellow fever, chikungunya, and Zika… Read More...
Technology A Bold Effort to Cure HIV—Using Crispr Kevin Colleran Oct 5, 2022 Dornbusch thinks this strategy will spare patients from serious side effects or “off-target” edits—unintentional cuts… Read More...